By enhancing the accumulation of immune checkpoint inhibitors at the tumor site, these novel nanoparticles can promote the localized secretion of cytokines such as TNF-α and INF-γ, and potentiates the anti-tumor immune response in PAAD. The gene discussed is TNF; the disease is pancreatic adenocarcinoma.